DCXAb Vaccination Requires CD40 for Tumor Immunity.
收藏数据链接：
官方服务：
资源简介：
Normal mice received 2×106 wild-type or CD40−/− DC pulsed with B16 tumor lysate and control antibody or B7-DC XAb as indicated. On the same day, 5×105 B16 tumor cells were implanted on the right flank. The animals were monitored for tumor growth for at least 90 days and were euthanized if the tumor reached 17×17 mm. The scores indicate the number of mice in the indicated treatment group remaining free of tumor. n.s. = not significant.
创建时间：
2015-12-02
